Table 4.
Differences between linear measurements obtained by the reference protocol (reference dose/filtered back-projection) and the various test protocols
| Mean difference (mm)* | Standard deviation of difference (mm) | 95% confidence interval limits (mm) | Significance (linear regression) | ||
|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||
| LD1/FBP | − 0.2083 | 0.61128 | − 0.3662 | − 0.0504 | 0.605 |
| LD1/ASIR 50 | − 0.2817 | 0.66498 | − 0.4534 | − 0.1099 | 0.394 |
| LD1/ASIR 100 | − 0.3467 | 0.61959 | − 0.5067 | − 0.1866 | – |
| LD1/MBIR | − 0.4667 | 1.01508 | − 0.7289 | − 0.2044 | – |
| LD2/FBP | − 0.2500 | 0.76878 | − 0.4486 | − 0.0514 | 0.584 |
| LD2/ASIR 50 | − 0.6367 | 1.47269 | − 1.0171 | − 0.2562 | – |
| LD2/ASIR 100 | − 0.4050 | 0.55736 | − 0.5490 | − 0.2610 | – |
| LD2/MBIR | − 0.4583 | 1.05899 | − 0.7319 | − 0.1848 | – |
– Bland–Altman plot and linear regression were not performed because the one-sample t test demonstrated a mean difference greater than ± 0.3 mm with 95% confidence limits greater than ± 0.5 mm
LD low-dose protocol, FBP filtered back-projection, ASIR adaptive statistical iterative reconstruction, MBIR model-based iterative reconstruction
*All mean differences were statistically significant (p < 0.05)